{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:25:23Z","timestamp":1649103923839},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00393-018-0499-1","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T07:01:57Z","timestamp":1530082917000},"page":"484-492","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Was der Rheumatologe vom Dermatologen lernen kann \u2013 oder: Gute Freunde kann niemand trennen"],"prefix":"10.1007","volume":"77","author":[{"given":"K.","family":"Sch\u00e4kel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schirra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"issue":"5","key":"499_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N\u00a0Engl J Med 361(5):496\u2013509","journal-title":"N Engl J Med"},{"key":"499_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15867","author":"R Mossner","year":"2017","unstructured":"Mossner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Lohr S, Schulz P et al (2017) The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. \n                    https:\/\/doi.org\/10.1111\/bjd.15867","journal-title":"Br J Dermatol"},{"issue":"5","key":"499_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F et al (2013) Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J\u00a0Am Acad Dermatol 69(5):729\u2013735","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"499_CR4","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","volume":"75","author":"L Eder","year":"2016","unstructured":"Eder L, Wu Y, Chandran V, Cook R, Gladman DD (2016) Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis 75(9):1680\u20131686","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"499_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","volume":"4","author":"JN Gilliam","year":"1981","unstructured":"Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J\u00a0Am Acad Dermatol 4(4):471\u2013475","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"499_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","volume":"147","author":"AY Chang","year":"2011","unstructured":"Chang AY, Piette EW, Foering KP, Tenhave TR, Okawa J, Werth VP (2011) Response to antimalarial agents in cutaneous lupus erythematosus: a\u00a0prospective analysis. Arch Dermatol 147(11):1261\u20131267","journal-title":"Arch Dermatol"},{"issue":"6445","key":"499_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bmj.289.6445.576","volume":"289","author":"HJ Englert","year":"1984","unstructured":"Englert HJ, Hawkes CH, Boey ML, Derue GJ, Loizou S, Harris EN et\u00a0al (1984) Degos\u2019 disease: association with anticardiolipin antibodies and the lupus anticoagulant. Br Med J (Clin Res Ed) 289(6445):576","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"1","key":"499_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/WNL.53.1.223","volume":"53","author":"LA Kalashnikova","year":"1999","unstructured":"Kalashnikova LA, Korczyn AD, Shavit S, Rebrova O, Reshetnyak T, Chapman J (1999) Antibodies to prothrombin in patients with Sneddon\u2019s syndrome. Neurology 53(1):223\u2013225","journal-title":"Neurology"},{"issue":"19","key":"499_CR9","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N\u00a0Engl J Med 360(19):1989\u20132003","journal-title":"N Engl J Med"},{"issue":"11","key":"499_CR10","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et\u00a0al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"key":"499_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.03.019","author":"F Ingegnoli","year":"2018","unstructured":"Ingegnoli F, Schioppo T, Allanore Y, Caporali R, Colaci M, Distler O et\u00a0al (2018) Practical suggestions on intravenous iloprost in Raynaud\u2019s phenomenon and digital ulcer secondary to systemic sclerosis: systematic literature review and expert consensus. Semin Arthritis Rheum. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2018.03.019","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"499_CR12","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et\u00a0al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50(12):3985\u20133993","journal-title":"Arthritis Rheum"},{"issue":"5","key":"499_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269\u2013278","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"499_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","volume":"161","author":"YL Huang","year":"2009","unstructured":"Huang YL, Chen YJ, Lin MW, Wu CY, Liu PC, Chen TJ et al (2009) Malignancies associated with dermatomyositis and polymyositis in Taiwan: a\u00a0nationwide population-based study. Br J Dermatol 161(4):854\u2013860","journal-title":"Br J Dermatol"},{"key":"499_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/607921","author":"F Davatchi","year":"2012","unstructured":"Davatchi F (2012) Diagnosis\/classification criteria for Behcet\u2019s disease. Patholog Res Int. \n                    https:\/\/doi.org\/10.1155\/2012\/607921","journal-title":"Patholog Res Int"},{"issue":"10","key":"499_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1055\/s-0035-1553477","volume":"53","author":"S Schack","year":"2015","unstructured":"Schack S, Weber M, Oelzner P, Mireskandari M, Antonov D, Stallmach A (2015) Morbus Behcet or inflammatory bowel disease\u2014a diagnostic and therapeutic dilemma. Z\u00a0Gastroenterol 53(10):1187\u20131192","journal-title":"Z Gastroenterol"},{"issue":"6","key":"499_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/09273948.2013.854393","volume":"22","author":"I Tugal-Tutkun","year":"2014","unstructured":"Tugal-Tutkun I, Onal S, Ozyazgan Y, Soylu M, Akman M (2014) Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behcet uveitis. Ocul Immunol Inflamm 22(6):461\u2013468","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"499_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.1968.tb11898.x","volume":"80","author":"DI McCallum","year":"1968","unstructured":"McCallum DI, Kinmont PD (1968) Dermatological manifestations of crohn\u2019s disease. Br J Dermatol 80(1):1\u20138","journal-title":"Br J Dermatol"},{"issue":"2 Pt 2","key":"499_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0190-9622(92)70200-Y","volume":"27","author":"M Keltz","year":"1992","unstructured":"Keltz M, Lebwohl M, Bishop S (1992) Peristomal pyoderma gangrenosum. J\u00a0Am Acad Dermatol 27(2 Pt 2):360\u2013364","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"499_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1365-2133.2005.06467.x","volume":"152","author":"VG Hubbard","year":"2005","unstructured":"Hubbard VG, Friedmann AC, Goldsmith P (2005) Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 152(5):1059\u20131061","journal-title":"Br J Dermatol"},{"issue":"3","key":"499_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6","volume":"43","author":"C Garcia-Porrua","year":"2000","unstructured":"Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, Lopez-Lazaro L, Lueiro M, Fernandez ML et al (2000) Erythema nodosum: etiologic and predictive factors in a\u00a0defined population. Arthritis Rheum 43(3):584\u2013592","journal-title":"Arthritis Rheum"},{"issue":"10106","key":"499_CR22","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O (2017) Severe cutaneous adverse reactions to drugs. Lancet 390(10106):1996\u20132011","journal-title":"Lancet"},{"issue":"1","key":"499_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","volume":"157","author":"L Fardet","year":"2007","unstructured":"Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C et al (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol 157(1):142\u2013148","journal-title":"Br J Dermatol"},{"issue":"3","key":"499_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000446692","volume":"8","author":"K Knoll","year":"2016","unstructured":"Knoll K, Anzengruber F, Cozzio A, French LE, Murer C, Navarini AA (2016) Mucocutaneous ulcerations and pancytopenia due to methotrexate overdose. Case Rep Dermatol 8(3):287\u2013293","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"499_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ki.2013.319","volume":"85","author":"KE Chen","year":"2014","unstructured":"Chen KE, Yang CC, Lee Y\u2011YJ, Sung JM (2014) Widespread skin necrosis due to methotrexate overdose in a\u00a0patient with CKD. Kidney Int 85(3):716\u2013717","journal-title":"Kidney Int"},{"issue":"2","key":"499_CR26","first-page":"e325","volume":"9","author":"EM Kalogirou","year":"2017","unstructured":"Kalogirou EM, Katsoulas N, Tosios KI, Lazaris AC, Sklavounou A (2017) Non-healing tongue ulcer in a\u00a0rheumatoid arthritis patient medicated with leflunomide. An adverse drug event? J\u00a0Clin Exp Dent 9(2):e325\u2013e328","journal-title":"J Clin Exp Dent"},{"issue":"5","key":"499_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11926-016-0572-1","volume":"18","author":"S Vallabhaneni","year":"2016","unstructured":"Vallabhaneni S, Chiller TM (2016) Fungal infections and new biologic therapies. Curr Rheumatol Rep 18(5):29","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"499_CR28","first-page":"1111","volume":"15","author":"O Brandt","year":"2017","unstructured":"Brandt O, Bircher AJ (2017) Delayed-type hypersensitivity to oral and parenteral drugs. J\u00a0Dtsch Dermatol Ges 15(11):1111\u20131132","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"499_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1471-4906(03)00142-X","volume":"24","author":"TV Rajan","year":"2003","unstructured":"Rajan TV (2003) The Gell-Coombs classification of hypersensitivity reactions: a\u00a0re-interpretation. Trends Immunol 24(7):376\u2013379","journal-title":"Trends Immunol"},{"issue":"3 Suppl","key":"499_CR30","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.jaci.2010.11.048","volume":"127","author":"WJ Pichler","year":"2011","unstructured":"Pichler WJ, Naisbitt DJ, Park BK (2011) Immune pathomechanism of drug hypersensitivity reactions. J\u00a0Allergy Clin Immunol 127(3 Suppl):S74\u2013S81","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"499_CR31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/gut.2008.163683","volume":"58","author":"JF Kerbleski","year":"2009","unstructured":"Kerbleski JF, Gottlieb AB (2009) Dermatological complications and safety of anti-TNF treatments. Gut 58(8):1033\u20131039","journal-title":"Gut"},{"issue":"3","key":"499_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/ard.2005.037424","volume":"65","author":"S Kary","year":"2006","unstructured":"Kary S, Worm M, Audring H, Huscher D, Renelt M, Sorensen H et\u00a0al (2006) New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 65(3):405\u2013407","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"499_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/09546630802441234","volume":"20","author":"JM Ko","year":"2009","unstructured":"Ko JM, Gottlieb AB, Kerbleski JF (2009) Induction and exacerbation of psoriasis with TNF-blockade therapy: a\u00a0review and analysis of 127 cases. J\u00a0Dermatolog Treat 20(2):100\u2013108","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"499_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar2341","volume":"10","author":"M Aringer","year":"2008","unstructured":"Aringer M, Smolen JS (2008) The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 10(1):202","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"499_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bjd.15830","volume":"178","author":"E Peleva","year":"2018","unstructured":"Peleva E, Exton LS, Kelley K, Kleyn CE, Mason KJ, Smith CH (2018) Risk of cancer in patients with psoriasis on biological therapies: a\u00a0systematic review. Br J Dermatol 178(1):103\u2013113","journal-title":"Br J Dermatol"},{"issue":"9","key":"499_CR36","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","volume":"55","author":"E Lange","year":"2016","unstructured":"Lange E, Blizzard L, Venn A, Francis H, Jones G (2016) Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a\u00a0retrospective cohort study. Rheumatology (Oxford) 55(9):1594\u20131600","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"499_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/DSS.0000000000001455","volume":"44","author":"JW Hagen","year":"2018","unstructured":"Hagen JW, Pugliano-Mauro MA (2018) Nonmelanoma skin cancer risk in patients with inflammatory bowel disease undergoing thiopurine therapy: a systematic review of the literature. Dermatol Surg 44(4):469\u2013480","journal-title":"Dermatol Surg"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0499-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T23:27:00Z","timestamp":1561591620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0499-1"}},"subtitle":["Schnittpunkte der beiden Dom\u00e4nen"],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0499-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"27 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Sch\u00e4kel und A.\u00a0Schirra geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}